Similar articles

• Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide.

  Fidler IJ, Fogler WE, Brownbill AF, Schumann G. Fidler IJ, et al. J Immunol. 1987 Jun 15;138(12):4509-14. J Immunol. 1987. PMID: 3584979
• Treatment of experimental lung metastasis with local thoracic irradiation followed by systemic macrophage activation with liposomes containing muramyl tripeptide.

  Saiki I, Milas L, Hunter N, Fidler IJ. Saiki I, et al. Cancer Res. 1986 Oct;46(10):4966-70. Cancer Res. 1986. PMID: 3756858
• Potent in situ activation of murine lung macrophages and therapy of melanoma metastases by systemic administration of liposomes containing muramyltripeptide phosphatidylethanolamine and interferon gamma.

  Fidler IJ, Fan D, Ichinose Y. Fidler IJ, et al. Invasion Metastasis. 1989;9(2):75-88. Invasion Metastasis. 1989. PMID: 2496047
• Role of alveolar macrophages in pulmonary neoplasias.

  Sone S. Sone S. Biochim Biophys Acta. 1986;823(3):227-45. doi: 10.1016/0304-419x(86)90004-1. Biochim Biophys Acta. 1986. PMID: 2423125 Review. No abstract available.
• Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.

  Kleinerman ES. Kleinerman ES. Hematol Oncol Clin North Am. 1995 Aug;9(4):927-38. Hematol Oncol Clin North Am. 1995. PMID: 7490249 Review.